Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  TEL AVIV STOCK EXCHANGE  >  Teva Pharmaceutical Industries Limited    TEVA   IL0006290147

 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Tel Aviv Stock Exchange
03/19/2017 03/20/2017 03/21/2017 03/22/2017 03/23/2017 Date
12220(c) 12160(c) 11970(c) 11870(c) 12020(c) Last
130 416 289 330 552 112 642 422 669 422 Volume
+0.08% -0.49% -1.56% -0.84% +1.26% Change
More quotes
Financials ($)
Sales 2017 23 456 M
EBIT 2017 7 071 M
Net income 2017 4 011 M
Debt 2017 25 854 M
Yield 2017 3,63%
Sales 2018 23 190 M
EBIT 2018 7 119 M
Net income 2018 4 202 M
Debt 2018 21 087 M
Yield 2018 3,69%
P/E ratio 2017 8,41
P/E ratio 2018 8,14
EV / Sales2017 2,53x
EV / Sales2018 2,35x
Capitalization 33 487 M
More Financials
Company
Teva Pharmaceutical Industries Ltd. engages in the provision of pharmaceutical services.It operates through the following two segments: Generic and Specialty Medicine.The Generic segment includes chemical and therapeutic equivalents of originator medicines in a variety of dosage forms, including... 
Sector
Pharmaceuticals
Calendar
05/04Earnings Release
More about the company
Surperformance© ratings of Teva Pharmaceutical Indust
Trading Rating : Investor Rating :
More Ratings
Latest news on TEVA PHARMACEUTICAL INDUST
03/23 TEVA PHARMACEUTICAL INDUSTRIES : fires dozens in Israel
03/23 TEVA PHARMACEUTICAL INDUSTRIES : Announces Launch of Authorized Generic of Minas..
03/23 TEVA PHARMACEUTICAL INDUSTRIES : Pharm says media reports of up to 6,000 layoffs..
03/20 TEVA PHARMACEUTICAL INDUSTRIES LTD ( : TEVA) Launches Minastrin Generic In The U..
03/16 TEVA PHARMACEUTICAL INDUSTRIES : New Findings Reported from Teva Pharmaceutical ..
03/16 TEVA PHARMACEUTICAL INDUSTRIES : Announces Launch of Authorized Generic of Minas..
03/13 TEVA PHARMACEUTICAL INDUSTRIES : to Present at the Barclays Global Annual Health..
03/13 OBEROI REALTY : Samsung leases 1.1 lakh square feet for office in mumbai for nin..
03/12 TEVA PHARMACEUTICAL INDUSTRIES : "Next 4 months most interesting in Teva's histo..
03/12 TEVA PHARMACEUTICAL INDUSTRIES : Philips Israel incubator selects 9 projects
More news
Sector news : Pharmaceuticals - NEC
03/24 NOVO NORDISK A/S : EMA panel backs Novo Nordisk's haemophilia B drug
03/24 YouTube's bid to grab TV dollars imperiled by advertiser revolt
03/23DJPRESS RELEASE : FDA Grants Approval for -3-
03/23DJPRESS RELEASE : FDA Grants Approval for -2-
03/23DJPRESS RELEASE : FDA Grants Approval for BAVENCIO(R) (avelumab), the First Immuno..
More sector news : Pharmaceuticals - NEC
Latest Tweets
03/24Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Launches Minastrin Generic In.. 
03/23Teva Pharmaceutical to cut up to 6,000 jobs: Report
1
03/23Teva Pharmaceutical plans to cut as many as 6,000 jobs, an Israeli newspaper ..
19
03/23Teva Pharmaceutical Industries : Pharm may fire 6,000 workers - Israeli media.. 
03/23Teva Pharmaceutical Industries Ltd downgraded by Vetr Inc. to buy. $36.12 PT... 
More tweets
Qtime:49
News from SeekingAlpha
07:30a MARKETPLACE ROUNDTABLE : Biotech Hanging In The Balance
03/24 BIOTECH FORUM DAILY DIGEST : Obamacare To Stay? Flexion On The Block? Spotlight ..
03/23 WALL STREET BREAKFAST : High Stakes For Healthcare Vote
03/23 Teva Pharm may fire 6,000 workers
03/21 UPCOMING EVENTS : Alder's Migraine Test, Paratek's Antibiotic
Advertisement
Chart TEVA PHARMACEUTICAL INDUST
Duration : Period :
Teva Pharmaceutical Indust Technical Analysis Chart | TEVA | IL0006290147 | 4-Traders
Full-screen chart
Technical analysis trends TEVA PHARMACEUTIC...
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 2
Average target price 46,0 $
Spread / Average Target 39%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Yitzhak Peterburg President & Chief Executive Officer
Sol J. Barer Chairman
Carlo de Notaristefani President & CEO-Global Operations
Eyal Desheh Chief Financial Officer & Group Executive VP
Michael R. Hayden President-Global Research & Development
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
TEVA PHARMACEUTICAL IN..-12.65%33 487
JOHNSON & JOHNSON8.91%340 163
ROCHE HOLDING LTD.8.60%219 545
PFIZER INC.4.68%202 474
NOVARTIS AG-0.94%195 096
MERCK & CO., INC.7.32%173 465
More Results